Another transgenic zebrafish that is used to study hepatic steatosis was generated by expressing a dominant-negative Fgf receptor mutation specifically in hepatocytes (lfabp:dnfgfr1-egfp) (Tsai et al., 2013). Here, FABP1 is linked to fatty liver disease.